SANDARE NITROPRUSSIDE TEST PROCEDURE— 510(k) K810514

Name: FDA 510(k) clearance K810514
Creator: U.S. Food and Drug Administration
Published: 1981-03-04

Substantially Equivalent

Sandare Chemical Co., Inc.

FDA 510(k) clearance K810514 for SANDARE NITROPRUSSIDE TEST PROCEDURE, Substantially Equivalent on 1981-03-04. Applicant: Sandare Chemical Co., Inc.. Device class: 1.

Clearance details

Applicant: Sandare Chemical Co., Inc.
Product code: Code JLC
Device class: Class 1
Regulation: 21 CFR 862.1240
Advisory panel: Clinical Chemistry
Date received: 1981-02-25
Decision date: 1981-03-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JLC

view all

K843382 — UROCYSTIN1985-01-08

More clearances from Sandare Chemical Co., Inc.

view all

K872852 — EAGLE DIAGNOSTICS GLYCOHEMOGLOBIN UNITIZED TEST1987-09-29
K862556 — SANDARE GLYCOHEMOGLOBIN PROCEDURE1986-08-08
K860684 — SANDARE BCG ALBUMIN PROCEDURE1986-03-17
K851395 — SANDARE IRON-BINDING CAPACITY PROCEDURE1985-05-07
K851394 — SANDARE IRON PROCEDURE1985-04-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.